Butyrate Inhibits the HDAC8/NF-κB Pathway to Enhance Slc26a3 Expression and Improve the Intestinal Epithelial Barrier to Relieve Colitis
Kaixin Peng(Tongji Hospital), Qin Yu(Huazhong University of Science and Technology), Siqi Xiao(Tongji Hospital), Hongbing Yu(University of British Columbia), C.-L. Li(Tongji Hospital), Suhong Xia(Center for Digestive and Liver Diseases)
Cited by 60
Related Papers
The role of Lactobacillus in inflammatory bowel disease: from actualities to prospects
|Cell Death Discovery|2023|184
Short‐chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
|Journal of Gastroenterology and Hepatology|2022|58
The role of sphingosine-1-phosphate in autophagy and related disorders
|Cell Death Discovery|2023|40
Tumor necrosis factor-α acts reciprocally with solute carrier family 26, member 3, (downregulated-in-adenoma) and reduces its expression, leading to intestinal inflammation
|International Journal of Molecular Medicine|2017|24